Departments of Medicine.
Departments of Epidemiology & Biostatistics.
J Heart Lung Transplant. 2019 Jul;38(7):699-707. doi: 10.1016/j.healun.2019.03.006. Epub 2019 Mar 18.
Frailty is common in adults with advanced lung disease and is associated with death before and after lung transplantation. We aimed to determine whether frailty changes from before to after the lung transplant.
In a single-center, prospective cohort study among adults undergoing lung transplantation from 2010 to 2017, we assessed frailty by the Short Physical Performance Battery (SPPB; higher scores reflect less frailty) and Fried Frailty Phenotype (FFP; higher scores reflect greater frailty) before and repeatedly up to 36 months after transplant. We tested for changes in frailty scores over time using segmented mixed effects models, adjusting for age, sex, and diagnosis. We quantified the proportion of subjects transitioning between frailty states (frail vs not frail) from before to after the transplant.
In 246 subjects, changes in frailty occurred within the first 6 post-operative months and remained stable thereafter. The overall change in frailty was attributable to improvements among those subjects who were frail before transplant. They experienced a 5.1-point improvement in SPPB (95% confidence interval [CI] 4.6-5.7) and a 1.8-point improvement in FFP (95% CI -2.1 to -1.6) during the early period. Frailty by SPPB and FFP did not change in those who were not frail before transplant. Approximately 84% of survivors who were frail before transplant became not frail after transplant.
Pre-operative frailty resolves in many patients after lung transplantation. Because a large proportion of frailty may be attributable to advanced lung disease, frailty alone should not be an absolute contraindication to transplantation.
衰弱在患有晚期肺部疾病的成年人中很常见,并且与肺移植前后的死亡有关。我们旨在确定肺移植前后衰弱是否会发生变化。
在 2010 年至 2017 年期间进行肺移植的成年人的单中心前瞻性队列研究中,我们使用简短体能表现电池(SPPB;分数越高表示衰弱程度越低)和 Fried 衰弱表型(FFP;分数越高表示衰弱程度越高)在移植前和移植后最多 36 个月内反复评估衰弱情况。我们使用分段混合效应模型来测试随时间推移的衰弱评分变化,调整了年龄、性别和诊断因素。我们量化了从移植前到移植后衰弱状态(衰弱与非衰弱)之间转换的受试者比例。
在 246 名受试者中,衰弱变化发生在术后的前 6 个月内,此后保持稳定。总体衰弱变化归因于移植前衰弱的受试者的改善。他们的 SPPB 得分提高了 5.1 分(95%置信区间 [CI] 4.6-5.7),FFP 得分提高了 1.8 分(95%CI -2.1 至-1.6)。在早期,移植前非衰弱的受试者中 SPPB 和 FFP 的衰弱没有变化。大约 84%的移植前衰弱的幸存者在移植后变得不衰弱。
肺移植后,许多患者的术前衰弱得到缓解。由于衰弱的很大一部分可能归因于晚期肺部疾病,因此衰弱本身不应成为移植的绝对禁忌症。